MERZOUKI ABDERRAZZAK (Chief Operating Officer) received a stock award from SUNSHINE BIOPHARMA INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 7/13/2020ACC: 0001128732-20-000004
DirectorOfficer· Chief Operating Officer
Since Aug 2018
+2.40M
Net shares
Net buyer
$2.4K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
2.40M acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.10M
Price / share
$0.00
Trade value
$1.10K
% of position
116.7%
10/20/2019
942.50K→2.04M
Common Stock
Direct
Shares
+1.30M
Price / share
$0.00
Trade value
$1.30K
% of position
63.6%
12/19/2019
2.04M→3.34M
Total
Net shares
+2.40M
Net value
$2.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/20/2019 | A · Award | +1.10M | $0.00 | $1.10K | 116.7% | 942.50K | 2.04M |
| Common Stock Direct | 12/19/2019 | A · Award | +1.30M | $0.00 | $1.30K | 63.6% | 2.04M | 3.34M |
| Total | +2.40M | $2.40K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned3.67K
Total
3.67K indirect3.67K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.67K | Indirect |
| Total | 3.67K | 3.67K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported